Extensive research has highlighted the clinical significance of STMs such as carcinoembryonic antigen (CEA), squamous cell carcinoma antigen (SCCAg), and cytokeratin fragment 19 (CYFRA 21-1) in the context of NSCLC [7]. The gene discussed is CEACAM5; the disease is non-small cell lung carcinoma.